RAIN Rain Oncology Inc.

NASDAQ
$1.00

Rain Oncology Inc. (RAIN) is expected to report earnings on November 12, 2026, after the market close.

Rain Oncology Inc. Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
Earnings Date
Nov 12
Thursday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Rain Oncology Inc.

Rain Oncology Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.